Systemic interferon-alpha regulates interferon-stimulated genes in the central nervous system

Area of Science:

• Neuroscience
• Immunology
• Molecular Biology

Background:

• Interferon-alpha (IFN-alpha), a key antiviral cytokine, has known beneficial roles but is also linked to central nervous system (CNS) disorders.
• Systemic IFN-alpha administration in humans can lead to severe neuropsychiatric side effects like depression, anxiety, and cognitive deficits.
• The direct mechanism by which systemic IFN-alpha exerts its effects on the brain remains unclear.

Purpose of the Study:

• To investigate whether systemic interferon-alpha (IFN-alpha) directly acts on the brain.
• To identify genes directly regulated by IFN-alpha signaling within the CNS.
• To elucidate the molecular pathways mediating IFN-alpha's CNS effects.

Main Methods:

• Administration of mouse IFN-alpha and human IFN-alpha to mice.
• Analysis of gene expression, focusing on IFN-stimulated genes (ISGs) in brain tissue.
• Utilized dual labeling in situ hybridization and immunocytochemistry to localize gene expression.
• Examined the response in STAT1 knockout mice.

Main Results:

• Intraperitoneal administration of mouse IFN-alpha, but not human IFN-alpha, activated key ISGs (STAT1, ISG15, USP18, GBP3) in the brain.
• The temporal expression profile of these ISGs in the brain mirrored that in peripheral organs.
• STAT1 transcripts were widely distributed in brain parenchyma, particularly in neurons.
• The CNS response to IFN-alpha was abolished in STAT1 knockout mice.

Conclusions:

• Systemic interferon-alpha (IFN-alpha) exerts direct, STAT1-dependent effects on the central nervous system (CNS).
• This STAT1-mediated pathway in the brain may underlie the neurological and neuropsychiatric complications observed with IFN-alpha therapy.
• Mouse IFN-alpha activates specific ISGs in the brain, suggesting a conserved mechanism.